Will V940 get approval from the FDA for lung cancer?
3
70Ṁ482030
71%
chance
1H
6H
1D
1W
1M
ALL
V940-002 is a personalized cancer vaccine (Moderna) + pembrolizumab (Merck). The trial (link) is on patients with resected non small cell lung cancer. Will it pass phase 3 and get approval?
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000People are also trading
Related questions
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
26% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
30% chance
Will AOH1996 be FDA approved before 2040?
40% chance